Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Cells, Tissues, Organs|July 30, 2019
A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management SystemPelin Kilic, Meltem Bay, Yasin Yildirim, et al.
Haematologica|February 9, 2018
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE studyAnne-Sophie Michallet, Melih Aktan, Wolfgang Hiddemann, et al.
Future Oncology (London, England)|June 9, 2023
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi studyMutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, et al.
Clinical Transplantation|July 27, 2020
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantationPinar Ataca Atilla, Erman Akkus, Erden Atilla, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|March 26, 2026
Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World ExperienceDerya Koyun, Uğur Şahin, Güldane Cengiz Seval, et al.
International Journal of Hematologic Oncology|June 6, 2022
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemiaGuray Saydam, Ridvan Ali, Ahmet Muzaffer Demir, et al.
British Journal of Haematology|February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN studyStephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Antiviral Therapy|July 5, 2018
Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?Erden Atilla, Merih Yalciner, Pinar Ataca Atilla, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|October 28, 2020
Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk FactorsZehra Narlı Özdemir, Uğur Şahin, Klara Dalva, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|November 9, 2002
Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yieldTaner Demirer, Osman Ilhan, Meltem Ayli, et al.
Pageof 14